Patient Preferences of a Resect and Discard Paradigm
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02305251|
Recruitment Status : Completed
First Posted : December 2, 2014
Last Update Posted : May 11, 2017
|Condition or disease||Intervention/treatment|
|Colonic Polyps||Other: Survey|
The American Society of Gastrointestinal Endoscopy (ASGE) published a review article on a new paradigm in colorectal cancer screening termed "resect and discard". This new paradigm challenges the current practice of sending all colorectal polyps, regardless of appearance or size, to pathology for analysis. "Resect and Discard" describes a new approach in which small polyps could be removed, but be discarded instead of sent for pathology analysis. This is based on data showing that gastroenterologists can predict the pathology of small colorectal polyps with 80-90% accuracy, and that discarding small polyps would not alter surveillance recommendations.
Neither the ASGE document nor published research, however, assessed patient attitudes toward this approach. This study surveyed patients prior to first time screening colonoscopy, in order to determine their preferences about the resect and discard approach; specifically would patients be willing to pay for pathology analysis of small colorectal polyps with their own money, and what factors influence their decision. We also inquired about factors that would influence their decision to pay/not pay pathology costs themselves.
|Study Type :||Observational|
|Actual Enrollment :||500 participants|
|Official Title:||Patient Preferences of a Resect and Discard Paradigm|
|Study Start Date :||June 2012|
|Actual Primary Completion Date :||March 2014|
|Actual Study Completion Date :||November 2, 2015|
- Other: Survey
Standard Gamble Survey
- Number of participants willing to pay out of pocket for pathology costs when a diminutive polyp is found. [ Time Frame: June, 2012 to March, 2014: up to 2 years ]This outcome is measured in percentage.
- The factors that influence patients' decisions to pay or not pay for pathology costs with their own money. [ Time Frame: June, 2012 to March, 2014: up to 2 years ]These factors were measured using univariate analysis with generation of odds ratios and 95% confidence intervals.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02305251
|United States, Missouri|
|Washington University in St. Louis|
|Saint Louis, Missouri, United States, 63110|
|Principal Investigator:||Dayna S Early, MD||Washington University School of Medicine|